Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Buy@47/48,'sell@51;over and over again
It rose to 400p but then you may have noticed the government stifled the travel industry by not adopting the EUs approach and the market due to uncertainty about social and economic factors outside of MNZ control have suppressed the market. Meanwhile MNZ grow through acquisition. It will be 475p as we unwind. Thanks for your attention.
ODX IS/HAS BEEN ramped too much. Today is a classic pump and dump on news that isn't coming. I hope I am wrong and you get a golden RNS tonight or in the morning. My opinion for the zero it is worth is the odds are stacked against. Even if I buy back in today it would still be at a much lower price than I sold at so I have no (further) loss to worry about.
calderkate hasn't got a single opinion on ODX
Twatch hasn't got a clue
Atanasoff has now gone from "overramped" to "pump and dump". I'm guessing he will move to "fraud" maybe even mention the CEO, "director sells" before lunch?
Atanasoff
Posted in: MNZS
RE: Rise coming soon11 May 2021 17:39
MNZS is a solid share and I expect it to be at 475p as we unwind lockdown.
different test
"Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that it has CE-Marked Mologic Ltd's ('Mologic') lateral flow antigen test for COVID-19, to be sold for professional-use under Omega's VISITECT® brand. "
March 2021.
For someone who literally spams the board I find it rather amusing that you didn't seem to know this. Anyway - back in the filter bin for you so don't bother replying, although I know you will.
Wasn't wrong about MNZs at all. They have won contracts, are substantial up from lows. They are naturally suffering - as are all travel stocks recently but they are well placed to deliver solid growth in the future.
Enjoy todays pump and dump everyone. Don't get burnt.
Atanasoff was wrong about MNZS, is he wrong about ODX, probably, maybe, who knows.
"For the thousandth time"
Might have bene 4 or 5, definitely not a 1000. We'll only know when the list is published whether it is a list of tests, or it is a list of retailers.
Still unclear to me when the government says unvalidated tests, surely they still means tests that have passed some level of saftey/ ce approval, and have just not been signed of for home testing in the uk. My understanding is that the visitect test has no ce/uk approval at all, even for professional use.
That’s it. So there is a good chance ODX’s test will be on the list, aswell as tests that ODX are providing cassettes for.
That's correct Jimi. Due to a danger of being short of supplies,the govt. stated that tests pending approvals would also be on the list.We are in week 6 of EU HUA .
I’m sure I read somewhere that the government is now allowing UK tests to be included who have begun validation/regulatory processes and are still waiting.
For the thousandth time - the test is not being named. The companies running the scheme will be. They will be able to select the tests that are authorised for self administration. Obviously if those suppliers also have a registration app or other logistics to support the testing process that may appeal to some suppliers who may want to white label the service.
Just to make it clear - unless ODX announce CE for self test along with an order then it is unlikely to happen. They are using the cassette machine to package. Nothing more or less. Not bad margins but nothing to compensate for the massive distraction of the last 2 years. It will have a tangible difference to the balance sheet and ongoing operations. It is clear the government will want to keep the lights on at Alva so this is a win. However, some of you seem to be on a totally different planet of expectations.
This share is over ramped and most will lose money on it.
I’m still researching here. Which test are holders expecting/hoping to see on tomorrow’s list?
Some investors "have to stay or sell at a considerable loss;imho;Roll on April(I mean tomorrow)
With the Government releasing the list of Lateral Flow tests for travel requirements tomorrow today is the day investors have to decide whether they want to be in or out of this share. With positive evidence accumulating by the day I know which camp I'm in.